FDA Says Drug Shortages Raise Risk of Cancer Counterfeits

• People also search for FDA CGMP Online Training - trusted FDA GMP online training courses offered by SkillsPlus International Inc.

Updated May 25, 2021

The original link broke.

You can still read more about this topic:

• FDA's Dear Doctor Letter: Re: Purchasing Medications from Foreign or Unlicensed Suppliers Could Result in Serious Harm to Patients; Counterfeit Altuzan Found in U.S. (PDF)
• Historical Information: FDA Issues Letters to Doctors Who May Have Purchased Counterfeit or Unapproved Prescription Drugs, 2012-2014 - FDA.gov

---  the original post follows below  ---

The FDA published this notice. Looks like drug shortages are opening doors for bad actors to take advantage of the situation.

FDA Notifies Health Care Providers about the Risks of Purchasing Unapproved Injectable Cancer Medications from Unlicensed Sources

Current shortages of injectable cancer medications may present an opportunity for unscrupulous individuals to introduce non-FDA approved products into the drug supply, which could result in serious harm to patients. Health care providers are reminded to obtain and use only FDA-approved injectable cancer medications purchased directly from the manufacturer or from wholesale distributors licensed in the United States (U.S.).

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - GMP Compliance Training Experts
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store